Physician profile
Ryan Choplin
NPI 1760729610
$9,987.79
in general payments reported to CMS, 2019-2025
44 companies · $2,964 in 2025
The $2,964 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.40 · 2022: $1,100 · 2023: $2,368 · 2024: $3,524 · 2025: $2,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,855.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,898.05 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,247.18 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $987.58 | 2022-2025 | |
| Pfizer INC. | $719.29 | 2022-2025 | |
| Lilly USA, LLC | $634.01 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $574.92 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.08 | 2022-2025 | Jardiance, Ofev, Synjardy |
| Amgen INC. | $317.69 | 2023-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $305.81 | 2022-2025 | Spravato |
| Phathom Pharmaceuticals, INC. | $286.87 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $242.80 | 2024-2025 | Sunosi, Auvelity |
| Corium, LLC | $216.94 | 2023-2024 | Azstarys |
| Abbott Laboratories | $212.95 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $205.55 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.89 | 2022-2025 | Xifaxan, Trulance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Choplin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.